跳至主要内容
临床试验/NCT05304650
NCT05304650Unknown4 期

A Usability Study of External Neuromodulation With iTEAR100 Generation 2

Olympic Ophthalmics, Inc.1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年3月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
入组人数
100
试验地点
1
主要终点
Usability

研究概览

简要总结

A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment.

详细描述

A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment. Subjects sign a consent form and are sent a device. After downloading a mobile app, they can access the device and download a prescription. At 7 days, an official telehealth visit evaluates their success in the set up and training. At 30 days, the trial ends, A usability survey and symptom evaluation survey are used to determine success.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Able to sign English language consent form and over age 18 and reside in the U.S.

排除标准

  • 未提供

研究组 & 干预措施

iTEAR100 Therapy

Other

Treatment Arm. Assessment of usability of generation 2 connected devices

干预措施: iTEAR100 (Device)

结局指标

主要结局

Usability

时间窗: 30 days

Subjects rate the device usability similar to daily mobile applications and home devices using a scale from -3 to +3 with 0 being same as every day devices such as bank application, restaurant application, etc.

次要结局

  • Adverse Events(30 days)
  • Symptom Score(30 Days)
  • Symptom Scores(30 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验